Jaguar Uranium grants CEO 400K options at $1

Two future vesting dates are conditional on each recipient's continued service through the applicable date.

Available on EDGAR 10/30/2026 - 05:00 PM EDT Accepted by SEC EDGAR 10/30/2026 - 05:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Jaguar Uranium Corp. granted options under its 2025 Equity Incentive Plan, as amended, on October 29, 2026: 400,000 options to purchase Class A common shares to President and Chief Executive Officer Steven Gold, 125,000 to Executive Chairman Luis Ducassi, and 200,000 to Chief Financial Officer William Avery. Each option has a $1.00 per-share exercise price. One-third vested on the grant date; one-third is scheduled to vest on April 29, 2027, and one-third on October 29, 2027, subject to continued service through each applicable vesting date. Each tranche is exercisable for five years from its vesting date and expires on October 29, 2031, April 29, 2032, and October 29, 2032, respectively.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Options granted to Steven Gold: 400,000 options to purchase Class A common shares Options granted to Luis Ducassi: 125,000 options to purchase Class A common shares Options granted to William Avery: 200,000 options to purchase Class A common shares +5 more

8 metrics

Options granted to Steven Gold 400,000 options to purchase Class A common shares President and Chief Executive Officer; granted October 29, 2026

Options granted to Luis Ducassi 125,000 options to purchase Class A common shares Executive Chairman; granted October 29, 2026

Options granted to William Avery 200,000 options to purchase Class A common shares Chief Financial Officer; granted October 29, 2026

Exercise price $1.00 per share For each option

Vesting portion One-third of the options Vested on the grant date; one-third portions are scheduled to vest on each of two later dates

Scheduled vesting date April 29, 2027 Subject to continued service through the applicable vesting date

Scheduled vesting date October 29, 2027 Subject to continued service through the applicable vesting date

Tranche expiration dates October 29, 2031; April 29, 2032; October 29, 2032 Each tranche is exercisable for five years from its vesting date

Key Terms

stock options, exercise price, vesting date, tranche

4 terms

stock options financial

"granted stock options to purchase Class A common shares"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"at an exercise price of $1.00 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting date financial

"Each tranche is exercisable for five years from its vesting date"

tranche financial

"Each tranche is exercisable for five years"

A tranche is one slice of a larger financing or investment that is released, sold, or paid out in separate parts rather than all at once. Investors care because each slice can carry different risk, return and timing—like buying pieces of a cake where some slices are richer or come later—so the specific tranche you hold affects when you get paid and how much you might gain or lose.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did JAGU grant to each officer?

Steven Gold, President and Chief Executive Officer, received options to purchase 400,000 shares; Executive Chairman Luis Ducassi received options to purchase 125,000 shares; and Chief Financial Officer William Avery received options to purchase 200,000 shares.

What are the exercise price and vesting terms for JAGU's options?

Each option has a $1.00 per-share exercise price. One-third vested on October 29, 2026, and one-third is scheduled to vest on each of April 29, 2027 and October 29, 2027, subject to continued service through the applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false 0002039273 A1 00-0000000 0002039273 2026-10-29 2026-10-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 29, 2026

Jaguar Uranium Corp.

(Exact name of registrant as specified in its charter)

British Columbia		001-43094		Not applicable
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3-1136 Centre Street
Thornhill, Ontario L4J 3M8
Canada

(Address of principal executive offices) (Zip Code)

(416) 648-4065 

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A common shares, no par value		JAGU		NYSE American LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 29, 2026 (the “Grant Date”), the Board of Directors of Jaguar Uranium Corp. (the “Company”) granted stock options (the “Options”) to purchase Class A common shares, no par value, of the Company (“Common Shares”) under the Jaguar Uranium Corp. 2025 Equity Incentive Plan, as amended, to the following officers: (i) Options to purchase 400,000 Common Shares to Steven Gold, President and Chief Executive Officer; (ii) Options to purchase 125,000 Common Shares to Luis Ducassi, Executive Chairman; and (iii) Options to purchase 200,000 Common Shares to William Avery, Chief Financial Officer. Each Option is exercisable for one Common Share at an exercise price of $1.00 per share. One-third of the Options vested on the Grant Date, one-third will vest on April 29, 2027 and one-third will vest on October 29, 2027, subject to the recipient’s continued service with the Company through each applicable vesting date. Each tranche is exercisable for five years from its vesting date and will expire on October 29, 2031, April 29, 2032 and October 29, 2032, respectively.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.

Date: October 30, 2026	Jaguar Uranium Corp.
	By:	/s/ Steven Gold
	Name:	Steven Gold
	Title:	President and Chief Executive Officer

2

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB